down arrow

China Regenerative Medicine International Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2129W1380
HKD
0.43
-0.12 (-20.91%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jul'17
Apr'17
Jan'17
Oct'16
Jul'16
Apr'16
Jan'16
Net Sales
71.06
83.09
245.65
25.53
2.72
10.38
12.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
71.06
83.09
245.65
25.53
2.72
10.38
12.37
Raw Material Cost
33.90
61.08
157.37
21.75
14.43
17.30
15.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
40.92
24.50
35.07
32.36
34.52
8.12
31.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.18
8.52
9.20
5.11
1.60
6.79
6.75
Selling and Distribution Expenses
94.67
101.23
72.95
58.37
65.49
36.76
69.66
Other Expenses
-4.20
-0.32
-3.95
-2.39
-2.82
1.01
-2.13
Total Expenditure (Excl Depreciation)
136.62
192.12
235.10
93.65
87.85
79.12
102.22
Operating Profit (PBDIT) excl Other Income
-65.6
-109
10.5
-68.1
-85.1
-68.7
-89.9
Other Income
3.99
5.62
5.62
4.87
4.54
12.43
35.24
Operating Profit (PBDIT)
-47.22
-78.60
28.93
-46.99
-67.61
-43.17
-42.32
Interest
9.18
8.52
9.20
5.11
1.60
6.79
6.75
Exceptional Items
0.83
19.67
13.28
0.00
0.00
8.56
0.00
Gross Profit (PBDT)
37.16
22.01
88.28
3.78
-11.71
-6.92
-3.38
Depreciation
14.21
16.40
12.76
13.03
12.99
13.13
12.29
Profit Before Tax
-69.78
-83.84
20.24
-65.12
-82.19
-54.55
-61.36
Tax
-1.83
-10.54
2.09
-1.63
-1.65
0.87
5.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-61.26
-57.77
11.46
-61.83
-76.36
-55.30
-67.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-61.26
-57.77
11.46
-61.83
-76.36
-55.30
-67.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.70
-15.54
6.70
-1.66
-4.19
-0.11
0.47
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-67.95
-73.31
18.15
-63.49
-80.54
-55.41
-67.33
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
0.00
1,877.04
0.00
1,917.90
0.00
2,066.36
0.00
Earnings per share (EPS)
-0.7
-0.66
0.13
-0.7
-0.87
-0.63
-0.77
Diluted Earnings per share
-0.7
-0.66
0.13
-0.7
-0.87
-0.63
-0.77
Operating Profit Margin (Excl OI)
-92.06%
-121.1%
4.29%
-254.09%
-3129.74%
-662.56%
-726.55%
Gross Profit Margin
-78.19%
-81.17%
13.44%
-204.03%
-2544.41%
-399.13%
-396.77%
PAT Margin
-86.2%
-69.53%
4.66%
-242.14%
-2807.17%
-533.01%
-548.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jul 2017 is 2,533.33% vs 68.75% in Jul 2016

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jul 2017 is 15.53% vs -73.49% in Jul 2016

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jul 2017 is 28.99% vs -79.80% in Jul 2016

stock-summary

Interest

YoY Growth in quarter ended Jul 2017 is 475.00% vs -71.93% in Jul 2016

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jul 2017 has improved from Jul 2016

Compare Quarterly Results Of China Regenerative Medicine International Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
71.06
0.00
71.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
71.06
0.00
71.06
Raw Material Cost
33.90
1.60
32.30
2,018.75%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
40.92
81.12
-40.20
-49.56%
Power Cost
0
0
0.00
Manufacturing Expenses
9.18
0.00
9.18
Selling and Distribution Expenses
94.67
80.68
13.99
17.34%
Other Expenses
-4.20
8.94
-13.14
-146.98%
Total Expenditure (Excl Depreciation)
136.62
252.78
-116.16
-45.95%
Operating Profit (PBDIT) excl Other Income
-65.56
-252.78
187.22
74.06%
Other Income
3.99
14.11
-10.12
-71.72%
Operating Profit (PBDIT)
-47.22
-237.07
189.85
80.08%
Interest
9.18
0.00
9.18
Exceptional Items
0.83
-475.20
476.03
100.17%
Gross Profit (PBDT)
37.16
-1.60
38.76
2,422.50%
Depreciation
14.21
1.60
12.61
788.12%
Profit Before Tax
-69.78
-713.87
644.09
90.23%
Tax
-1.83
0.00
-1.83
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-61.26
-176.31
115.05
65.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-61.26
-176.31
115.05
65.25%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-6.70
0.00
-6.70
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-67.95
-176.31
108.36
61.46%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
0.00
587.55
-587.55
-100.00%
Earnings per share (EPS)
-0.70
-0.18
-0.52
-288.89%
Diluted Earnings per share
-0.70
-0.18
-0.52
-288.89%
Operating Profit Margin (Excl OI)
-92.06%
0.00%
0.00
-92.06%
Gross Profit Margin
-78.19%
0.00%
0.00
-78.19%
PAT Margin
-86.20%
0.00%
0.00
-86.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.11 Million
in Jul 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Jul 2017 is -14.44% vs -66.16% in Apr 2017

stock-summary

YoY Growth in quarter ended Jul 2017 is 2,533.33% vs 68.75% in Jul 2016

Quarterly - Consolidate Net Profit
Consolidate Net Profit -6.80 Million
in Jul 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Jul 2017 is 7.23% vs -502.75% in Apr 2017

stock-summary

YoY Growth in quarter ended Jul 2017 is 15.53% vs -73.49% in Jul 2016

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.12 Million
in Jul 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Jul 2017 is 39.19% vs -461.37% in Apr 2017

stock-summary

YoY Growth in quarter ended Jul 2017 is 28.99% vs -79.80% in Jul 2016

Quarterly - Interest
Interest 0.92 Million
in Jul 2017

Figures in Million
stock-summary

QoQ Growth in quarter ended Jul 2017 is 8.24% vs -7.61% in Apr 2017

stock-summary

YoY Growth in quarter ended Jul 2017 is 475.00% vs -71.93% in Jul 2016

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -92.06%
in Jul 2017

Figures in %
stock-summary

QoQ Growth in quarter ended Jul 2017 has improved from Apr 2017

stock-summary

YoY Growth in quarter ended Jul 2017 has improved from Jul 2016

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."